Investors

Date	Name	Title	Type	Shares Traded	Price Range
Apr 12, 2010	vagelos p roy	Director	Disposition (Non Open Market)	7,952	n/a
Jun 18, 2010	vagelos p roy	Director	Disposition (Non Open Market)	31,761	n/a
Jul 2, 2010	vagelos p roy	Director	Disposition (Non Open Market)	9,021	n/a
Jul 7, 2010	vagelos p roy	Director	Disposition (Non Open Market)	125,000	n/a
Oct 4, 2010	vagelos p roy	Director	Disposition (Non Open Market)	8,035	n/a
Jan 4, 2011	vagelos p roy	Director	Disposition (Non Open Market)	6,311	n/a
Jan 12, 2011	vagelos p roy	Officer	Disposition (Non Open Market)	1,203	n/a
Apr 4, 2011	vagelos p roy	Officer	Disposition (Non Open Market)	4,954	n/a
Jan 8, 2013	vagelos p roy	Officer	Disposition (Non Open Market)	1,254	n/a
Apr 4, 2013	vagelos p roy	Officer	Disposition (Non Open Market)	1,215	n/a
May 6, 2013	van plew daniel p	Officer	Disposition (Non Open Market)	15,323	260.44
Apr 27, 2012	van plew daniel p	Officer	Disposition (Non Open Market)	15,990	138.36
Oct 25, 2012	van plew daniel p	Officer	Disposition (Non Open Market)	16,043	159.55
Feb 15, 2012	yancopoulos george	Officer	Disposition (Non Open Market)	67,017	109.29
May 6, 2013	yancopoulos george	Officer	Disposition (Non Open Market)	103,243	260.44
Jun 14, 2010	ryan arthur f	Director	Buy	10,000	26.98
Oct 13, 2010	sanofi	Beneficial Owner (10% or more)	Buy	1,017,401	28.00
May 18, 2010	sing george l	Director	Buy	5,000	28.44
May 18, 2010	sing george l	Director	Buy	2,500	28.64
Nov 13, 2009	sing george l	Director	Buy	10,000	18.78
Showing 341-360 of 633 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.